longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Evotec SE

EVO

1.6702.45% ( +0.040 )
Trading: Sep 17, 10:55:47 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -2.53, above the reasonable range, cheaper than 0.13% of the time in the past 3 years, and the industry ranks 33/59, the industry Median -1.55.

-2.53xP/E
$1.63Stock price
$-0.64Earnings per share
-2.53xP/E
Stock price$1.63Earnings per share$-0.64

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-7.47x
Typical range
-23.87x–-6.07x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-331.01x--$45.62B
CRLUSCharles River Laboratorie
-54.74x228.46%$13.05B
TEMUSTempus AI
-49.34x1.23%$12.55B
AVTRUSAvantor
-18.27x142.83%$10.56B
TXGUS10X Genomics
-126.05x105.18%$9.47B
BRKRUSBruker
-86.47x7.71%$9.24B
ADPTUSAdaptive Biotechnologies
-69.16x39.66%$4.42B
ABCLUSAbcellera Biologics
-22.97x34.69%$3.78B
ALMRUSAlamar Biosciences
-41.05x80.55%$2.04B
FTREUSFortrea
-22.29x93.77%$1.90B
MRVIUSMaravai LifeSciences
-22.95x65.83%$1.78B
PSNLUSPersonalis
-16.05x20.05%$1.72B
AZTAUSAzenta
-11.84x180.77%$1.45B
CYRXUSCryoport
-18.42x156.25%$836.22M
CTKBUSCytek Biosciences
-7.95x33.98%$640.82M
OABIUSOmniAb
-14.29x35.96%$632.45M
EVOUSEvotec SE
-2.53x390.22%$578.99M
DNAUSGinkgo Bioworks
-1.63x35.20%$475.42M
PACBUSPacific Biosc California
-3.17x75.82%$416.51M
TKNOUSAlpha Teknova
-22.76x5.80%$381.72M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.